Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis: A consensus statement from the Asia Scalp Psoriasis Study Group

Maria Lorna F. Frez, Pravit Asawanonda, Chalukya Gunasekara, Chuankeng Koh, Steven Loo, Hazel H. Oon, Vu Hong Thai, Tsen Fang Tsai, Sang Woong Youn

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Background: International consensus statements on the management of scalp psoriasis are available, but no such recommendations exist for Asia. Methods: The Asia Scalp Psoriasis Study Group (ASPSG) met in May 2011 to review the epidemiologic pattern of scalp psoriasis in Southeast Asia and to develop Asia-specific recommendations for its management. Results: The overall prevalence of psoriasis in Asia is <0.3%, but 75-90% have scalp involvement, whether isolated or with lesions elsewhere, which can negatively impact quality of life (QoL). Treatment decisions should be based primarily on objective disease severity, but should also take account of patient QoL. Psychosocial support and more aggressive treatment should be offered to all patients with moderate to severe QoL impairment. Topical therapy is indicated first-line in all patients, with combination therapy (corticosteroid + calcipotriol), more occlusive formulations, keratolytics, and very potent corticosteroids for patients needing greater or faster efficacy. Systemic therapies, light or laser treatments should be reserved for patients with severe and recalcitrant disease. Conclusions: The ASPSG recommends a patient-centered approach to scalp psoriasis management, consistent with the international consensus statements. Asian physicians should also consider patient QoL, prior treatment response, formulation preferences, likely adherence, cost, time available for self-management, and potential adverse events.

Original languageEnglish
Pages (from-to)38-45
Number of pages8
JournalJournal of Dermatological Treatment
Volume25
Issue number1
DOIs
StatePublished - 1 Feb 2014

Fingerprint

Scalp
Psoriasis
Quality of Life
Therapeutics
Adrenal Cortex Hormones
Southeastern Asia
Self Care
Lasers
Physicians
Light
Costs and Cost Analysis

Keywords

  • Asia
  • Consensus
  • Guidelines
  • Quality of life
  • Scalp psoriasis
  • Topical

Cite this

Frez, Maria Lorna F. ; Asawanonda, Pravit ; Gunasekara, Chalukya ; Koh, Chuankeng ; Loo, Steven ; Oon, Hazel H. ; Thai, Vu Hong ; Tsai, Tsen Fang ; Youn, Sang Woong. / Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis : A consensus statement from the Asia Scalp Psoriasis Study Group. In: Journal of Dermatological Treatment. 2014 ; Vol. 25, No. 1. pp. 38-45.
@article{9ef067da728c47f4aaa6ae4925e8a6b1,
title = "Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis: A consensus statement from the Asia Scalp Psoriasis Study Group",
abstract = "Background: International consensus statements on the management of scalp psoriasis are available, but no such recommendations exist for Asia. Methods: The Asia Scalp Psoriasis Study Group (ASPSG) met in May 2011 to review the epidemiologic pattern of scalp psoriasis in Southeast Asia and to develop Asia-specific recommendations for its management. Results: The overall prevalence of psoriasis in Asia is <0.3{\%}, but 75-90{\%} have scalp involvement, whether isolated or with lesions elsewhere, which can negatively impact quality of life (QoL). Treatment decisions should be based primarily on objective disease severity, but should also take account of patient QoL. Psychosocial support and more aggressive treatment should be offered to all patients with moderate to severe QoL impairment. Topical therapy is indicated first-line in all patients, with combination therapy (corticosteroid + calcipotriol), more occlusive formulations, keratolytics, and very potent corticosteroids for patients needing greater or faster efficacy. Systemic therapies, light or laser treatments should be reserved for patients with severe and recalcitrant disease. Conclusions: The ASPSG recommends a patient-centered approach to scalp psoriasis management, consistent with the international consensus statements. Asian physicians should also consider patient QoL, prior treatment response, formulation preferences, likely adherence, cost, time available for self-management, and potential adverse events.",
keywords = "Asia, Consensus, Guidelines, Quality of life, Scalp psoriasis, Topical",
author = "Frez, {Maria Lorna F.} and Pravit Asawanonda and Chalukya Gunasekara and Chuankeng Koh and Steven Loo and Oon, {Hazel H.} and Thai, {Vu Hong} and Tsai, {Tsen Fang} and Youn, {Sang Woong}",
year = "2014",
month = "2",
day = "1",
doi = "10.3109/09546634.2012.742176",
language = "English",
volume = "25",
pages = "38--45",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "1",

}

Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis : A consensus statement from the Asia Scalp Psoriasis Study Group. / Frez, Maria Lorna F.; Asawanonda, Pravit; Gunasekara, Chalukya; Koh, Chuankeng; Loo, Steven; Oon, Hazel H.; Thai, Vu Hong; Tsai, Tsen Fang; Youn, Sang Woong.

In: Journal of Dermatological Treatment, Vol. 25, No. 1, 01.02.2014, p. 38-45.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis

T2 - A consensus statement from the Asia Scalp Psoriasis Study Group

AU - Frez, Maria Lorna F.

AU - Asawanonda, Pravit

AU - Gunasekara, Chalukya

AU - Koh, Chuankeng

AU - Loo, Steven

AU - Oon, Hazel H.

AU - Thai, Vu Hong

AU - Tsai, Tsen Fang

AU - Youn, Sang Woong

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Background: International consensus statements on the management of scalp psoriasis are available, but no such recommendations exist for Asia. Methods: The Asia Scalp Psoriasis Study Group (ASPSG) met in May 2011 to review the epidemiologic pattern of scalp psoriasis in Southeast Asia and to develop Asia-specific recommendations for its management. Results: The overall prevalence of psoriasis in Asia is <0.3%, but 75-90% have scalp involvement, whether isolated or with lesions elsewhere, which can negatively impact quality of life (QoL). Treatment decisions should be based primarily on objective disease severity, but should also take account of patient QoL. Psychosocial support and more aggressive treatment should be offered to all patients with moderate to severe QoL impairment. Topical therapy is indicated first-line in all patients, with combination therapy (corticosteroid + calcipotriol), more occlusive formulations, keratolytics, and very potent corticosteroids for patients needing greater or faster efficacy. Systemic therapies, light or laser treatments should be reserved for patients with severe and recalcitrant disease. Conclusions: The ASPSG recommends a patient-centered approach to scalp psoriasis management, consistent with the international consensus statements. Asian physicians should also consider patient QoL, prior treatment response, formulation preferences, likely adherence, cost, time available for self-management, and potential adverse events.

AB - Background: International consensus statements on the management of scalp psoriasis are available, but no such recommendations exist for Asia. Methods: The Asia Scalp Psoriasis Study Group (ASPSG) met in May 2011 to review the epidemiologic pattern of scalp psoriasis in Southeast Asia and to develop Asia-specific recommendations for its management. Results: The overall prevalence of psoriasis in Asia is <0.3%, but 75-90% have scalp involvement, whether isolated or with lesions elsewhere, which can negatively impact quality of life (QoL). Treatment decisions should be based primarily on objective disease severity, but should also take account of patient QoL. Psychosocial support and more aggressive treatment should be offered to all patients with moderate to severe QoL impairment. Topical therapy is indicated first-line in all patients, with combination therapy (corticosteroid + calcipotriol), more occlusive formulations, keratolytics, and very potent corticosteroids for patients needing greater or faster efficacy. Systemic therapies, light or laser treatments should be reserved for patients with severe and recalcitrant disease. Conclusions: The ASPSG recommends a patient-centered approach to scalp psoriasis management, consistent with the international consensus statements. Asian physicians should also consider patient QoL, prior treatment response, formulation preferences, likely adherence, cost, time available for self-management, and potential adverse events.

KW - Asia

KW - Consensus

KW - Guidelines

KW - Quality of life

KW - Scalp psoriasis

KW - Topical

UR - http://www.scopus.com/inward/record.url?scp=84890542746&partnerID=8YFLogxK

U2 - 10.3109/09546634.2012.742176

DO - 10.3109/09546634.2012.742176

M3 - Review article

C2 - 23083439

AN - SCOPUS:84890542746

VL - 25

SP - 38

EP - 45

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 1

ER -